Patients with radiographic axial spondyloarthritis who receive ixekizumab biweekly demonstrate lower sacroiliac joint erosion and increased the backfill of new tissue through 52 weeks, according to ...
Axial involvement is present in approximately 25% of patients with PsA, with enthesitis, inflammatory bowel disease, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback